“…There are numerous second generation /I-sympathomimetic drugs available to fulfil this function (Renaud et al, 1974;Wilson and Fuchs, 1975;De Villiers, 1975;McDevitt et al, 1975;Anderson et al, 1975), but they have to be given intravenously to obtain a rapid onset of action, they are consequently not available to the patient at home, nor to outlying midwife obstetric units with no doctor in attendance where delay in treatment results in an increased morbidity and mortality. There are numerous second generation /I-sympathomimetic drugs available to fulfil this function (Renaud et al, 1974;Wilson and Fuchs, 1975;De Villiers, 1975;McDevitt et al, 1975;Anderson et al, 1975), but they have to be given intravenously to obtain a rapid onset of action, they are consequently not available to the patient at home, nor to outlying midwife obstetric units with no doctor in attendance where delay in treatment results in an increased morbidity and mortality.…”